Method of treating benign forgetfulness
CA 2389623 A1 · Owner: Hamilton, Nathan · Inventors: Hamilton, Nathan
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Disclosed herein are methods to treat cognition disorders particularly those , associated with aging. The method comprises administering a combination of a carnitine and an oxidant. Preferably the oxidant is thioctic acid. Preferably 0.12 grams to 3 grams of carnitine (particularly ALC) and 0.12 and 1.5 grams of R-(-lipoic acid are administered. Optionally coenzyme Q and/or creatine , also are administered. Preferably 10 mg to 500 mg/day of coenzyme Q10 and 1 to 30 grams/day of creatine are administered. The same method can be used to treat cognition deficits associated with carbon monoxide poisoning mild , traumatic brain injury, Type 2 diabetes mellitus obsessive-compulsive , …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed November 2, 2000. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended November 2, 2020.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by November 2, 2022.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.